COFCO Biotechnology Co., Ltd. (000930.SZ)
CNY 5.81
(-0.68%)
CNY 5.81
(-0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.96 Billion | 708.44 Million | 4.84 Billion | -2.91 Billion | 3.64 Billion | -923.31 Million |
| Net Income | -601.62 Million | 1.06 Billion | 1.13 Billion | 628.19 Million | 558.87 Million | 517.36 Million |
| Depreciation & Amortization | 509.2 Million | 458.18 Million | 446.28 Million | 436.39 Million | 425.28 Million | 609.45 Million |
| Deferred income taxes | -42.82 Million | 36.12 Million | -62.21 Million | -3.28 Million | -531.49 Thousand | -13.93 Million |
| Stock-based compensation | 3.8 Million | - | - | - | - | - |
| Change in working capital | 1.38 Billion | -1.26 Billion | 2.7 Billion | -4.47 Billion | 1.67 Billion | -2.88 Billion |
| Other non-cash items | 325.42 Million | 420.08 Million | 560.43 Million | 495.66 Million | 994.88 Million | 836.3 Million |
| Investing Cash Flow | -490.28 Million | -300.57 Million | -667.89 Million | -899.02 Million | -630.36 Million | -854.66 Million |
| Investments in PPE | -634.51 Million | -565.78 Million | -1.1 Billion | -987.51 Million | -900.76 Million | -868.35 Million |
| Acquisitions | 254.52 Million | 305.71 Million | 160.51 Million | 107.82 Million | 151.69 Million | 45.82 Million |
| Investment purchases | -118.76 Million | -32.63 Million | 270.39 Million | -21.13 Million | -32 Million | -79.32 Million |
| Sales/Maturities of investments | 8.89 Million | 14.78 Million | 1.6 Million | 6.32 Million | 106.68 Million | 47.18 Million |
| Other Investing Activities | -413.81 Thousand | -22.66 Million | 9.36 Million | -4.52 Million | 44.02 Million | -33.49 Million |
| Financing Cash Flow | -968.23 Million | -594.28 Million | -3.7 Billion | 3.75 Billion | -3.08 Billion | 1.32 Billion |
| Debt repayment | -323.08 Million | -6.49 Billion | -11.59 Billion | -5.56 Billion | -8.89 Billion | -7.61 Billion |
| Dividends payments | -1.06 Billion | -456.99 Million | -277.34 Million | -29.85 Million | -46.19 Million | -191.52 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -194.67 Million | 6.45 Billion | 8.16 Billion | 9.48 Billion | 6 Billion | 9.12 Billion |
| Accounts receivables | 1.01 Billion | -1.05 Billion | 2.41 Billion | -2.27 Billion | 960.77 Million | -629.07 Million |
| Accounts payables | -287.46 Million | -329.11 Million | -414.52 Million | 270.69 Million | -272.96 Million | -501.97 Million |
| Inventory | 679.82 Million | 83.07 Million | 760.34 Million | -2.46 Billion | 983.39 Million | -1.74 Billion |
| Other working capital | -14.35 Million | 36.12 Million | -62.21 Million | -3.28 Million | -531.5 Thousand | -1.14 Billion |
| Cash at beginning of period | 1.01 Billion | 1.1 Billion | 641.38 Million | 697.22 Million | 766.4 Million | 1.21 Billion |
| Cash at end of period | 1.48 Billion | 963.02 Million | 1.1 Billion | 641.38 Million | 697.22 Million | 766.4 Million |
| Capital Expenditure | -634.51 Million | -565.78 Million | -1.1 Billion | -987.51 Million | -900.76 Million | -868.35 Million |
| Effect of forex changes on cash | 11.07 Million | 40.36 Million | -4.32 Million | -536.43 Thousand | 1.42 Million | 5.67 Million |
| Net cash flow / Change in cash | 464.5 Million | -146.05 Million | 467.68 Million | -55.83 Million | -69.17 Million | -449.59 Million |
| Free Cash Flow | 1.32 Billion | 142.66 Million | 3.73 Billion | -3.89 Billion | 2.74 Billion | -1.79 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.87 Million | 36.64 Million | 24.84 Million | -268.76 Million | -601.62 Million | 2.37 Million |
| Depreciation & Amortization | - | 130.83 Million | 130.83 Million | 129.3 Million | 509.2 Million | -240.13 Million |
| Deferred income taxes | - | - | - | - | -42.82 Million | -1.09 Billion |
| Stock-based compensation | - | 587.8 Thousand | - | 3.8 Million | 3.8 Million | -1.31 Million |
| Change in working capital | - | -1.76 Billion | - | 1.67 Billion | 1.38 Billion | 1.33 Billion |
| Other non-cash items | 1.21 Billion | 445.65 Million | -1.43 Billion | 1.09 Billion | 325.42 Million | 2.42 Billion |
| Investing Cash Flow | 17.53 Million | 29.79 Million | -280.69 Million | -197.17 Million | -490.28 Million | 2.98 Million |
| Investments in PPE | -119.35 Million | -62.05 Million | -130.44 Million | -143.94 Million | -634.51 Million | -154.08 Million |
| Acquisitions | 150.42 Thousand | 16.07 Million | 122.95 Thousand | 46.28 Million | 254.52 Million | 160.16 Million |
| Investment purchases | 452.65 Million | -452.65 Million | - | -118.76 Million | -118.76 Million | 15.29 Million |
| Sales/Maturities of investments | -378.05 Million | 378.05 Million | - | 8.89 Million | 8.89 Million | -7.9 Million |
| Other Investing Activities | 136.89 Million | 150.37 Million | -150.37 Million | 18.05 Million | -413.81 Thousand | -10.47 Million |
| Financing Cash Flow | -1.36 Billion | 33.31 Million | 1.5 Billion | -669.65 Million | -968.23 Million | -2.81 Billion |
| Debt repayment | -1.21 Billion | -110.53 Million | -1.53 Billion | -633.37 Million | -323.08 Million | -2.56 Billion |
| Dividends payments | -26.22 Million | -26.66 Million | -20.18 Million | -1.06 Billion | -1.06 Billion | -618.12 Million |
| Common Stock Repurchased | - | -20.8 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -121.01 Million | -67.73 Million | -25.66 Million | 1.06 Billion | -194.67 Million | 371.91 Million |
| Accounts receivables | - | -765.21 Million | - | 1.01 Billion | 1.01 Billion | -596.63 Million |
| Accounts payables | - | - | - | - | -287.46 Million | 1.2 Million |
| Inventory | - | -1 Billion | - | 679.82 Million | 679.82 Million | 1.92 Billion |
| Other working capital | - | 602 Thousand | - | -14.35 Million | -14.35 Million | -1.2 Million |
| Cash at beginning of period | 1.67 Billion | 1.26 Billion | 1.48 Billion | 1.62 Billion | 1.01 Billion | 2.02 Billion |
| Cash at end of period | 1.55 Billion | 1.67 Billion | 1.26 Billion | 1.48 Billion | 1.48 Billion | 1.62 Billion |
| Capital Expenditure | -119.35 Million | -62.05 Million | -130.44 Million | -143.94 Million | -634.51 Million | -154.08 Million |
| Effect of forex changes on cash | 62 Million | -2.74 Million | -24.2 Million | 26.19 Million | 11.07 Million | -19.21 Million |
| Net cash flow / Change in cash | -120.74 Million | 411.94 Million | -214.5 Million | -144.19 Million | 464.5 Million | -403.05 Million |
| Free Cash Flow | 1.04 Billion | 289.41 Million | -1.54 Billion | 552.5 Million | 1.32 Billion | 2.27 Billion |
HEN
ESLA
CNNC
CMPO
SDZNY
DQJCY